BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8898452)

  • 21. Aspirin and the prevention of colorectal cancer.
    Ferrández A; Piazuelo E; Castells A
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention.
    Chan AT
    Cancer Causes Control; 2003 Jun; 14(5):413-8. PubMed ID: 12946035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aspirin and NSAIDs on colorectal adenomas. Protective effect may be spurious.
    Lo SV; Perry HU; Lyons R
    BMJ; 1993 Sep; 307(6906):734. PubMed ID: 8401104
    [No Abstract]   [Full Text] [Related]  

  • 24. Colorectal cancer and nonsteroidal anti-inflammatory drugs.
    Smalley WE; DuBois RN
    Adv Pharmacol; 1997; 39():1-20. PubMed ID: 9160111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin and NSAIDs for the prevention of colorectal cancer.
    Baron JA
    Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
    Mujtaba S; Bostick RM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1318-1326. PubMed ID: 30161027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
    Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
    Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
    Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.
    Sandler RS; Galanko JC; Murray SC; Helm JF; Woosley JT
    Gastroenterology; 1998 Mar; 114(3):441-7. PubMed ID: 9496933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
    Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
    Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
    Kraus S; Sion D; Arber N
    Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin as a chemoprevention agent for colorectal cancer.
    Lee CS; McNamara D; O'Morain CA
    Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do older adults using NSAIDs have a reduced risk of colorectal cancer?
    Hoffmeister M; Chang-Claude J; Brenner H
    Drugs Aging; 2006; 23(6):513-23. PubMed ID: 16872234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
    Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
    Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of colorectal cancer by aspirin use.
    Giovannucci E
    Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin for persons at higher risk for colorectal neoplasia.
    Ritt M
    J Fam Pract; 2004 Aug; 53(8):637-8; author reply 638. PubMed ID: 15298835
    [No Abstract]   [Full Text] [Related]  

  • 40. Can aspirin prevent colorectal cancer?
    Chan AT
    Lancet; 2007 May; 369(9573):1577-8. PubMed ID: 17499581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.